Financhill
Back

Grifols SA 10K Form

Buy
65

GRFS
Grifols SA

Last Price:
6.38
Seasonality Move:
5.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GRFS News And Ratings

See the #1 stock for the next 7 days that we like better than GRFS

GRFS Financial Statistics

Sales & Book Value

Annual Sales: $7.14B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $9.49
Price / Book: 0.67

Profitability

EPS (TTM): 0.31110
Net Income (TTM): $211.12M
Gross Margin: $2.7B
Return on Equity: 2.36%
Return on Assets: 0.9%

Grifols SA Earnings Forecast

Key Grifols SA Financial Ratios

  • The Gross Profit Margin over the past 19 years for GRFS is 37.84%.
  • The Selling, General & Administrative Expenses for GRFS have been equal to 19.11% of Gross Profit Margin.
  • The Research & Development expenses have been 6.00% of Revenue.
  • The Interest Expense is 870.03% of Operating Income.
  • The Net Earning history of GRFS is 0.90% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 11 years.

Grifols SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GRFS
CUSIP: 398438
Website: grifols.com

Debt

Debt-to-Equity Ratio: 1.55
Current Ratio: 2.79
Quick Ratio: 0.63

Price-to-Earnings

Trailing P/E Ratio: 65.48
Forward P/E Ratio: 3.97

GRFS Technical Analysis vs Fundamental Analysis

Buy
65
Grifols SA (GRFS) is a Buy

Is Grifols SA a Buy or a Sell?

  • Grifols SA stock is rated a Buy
    The current Grifols SA [GRFS] share price is $6.38. The Score for GRFS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.